Lexicon Pharmaceuticals Announces 2024 Annual Meeting of Stockholders
Ticker: LXRX · Form: DEF 14A · Filed: Mar 26, 2024
Sentiment: neutral
Topics: Lexicon Pharmaceuticals, Annual Meeting, Proxy Statement, Virtual Meeting, Stockholder Participation
TL;DR
Lexicon Pharmaceuticals will hold its 2024 annual meeting entirely online on May 10, 2024, requiring a control number for virtual attendance and participation.
AI Summary
LEXICON PHARMACEUTICALS, INC. (LXRX) filed a Proxy Statement (DEF 14A) with the SEC on March 26, 2024. The 2024 annual meeting of Lexicon Pharmaceuticals, Inc. stockholders will be held online on May 10, 2024, at 8:00 a.m. CDT. Stockholders can attend and participate by visiting www.virtualshareholdermeeting.com/LXRX2024. Electronic voting and question submission will be available during the virtual meeting. In-person attendance will not be possible. A 16-digit control number, included with proxy materials, is required for attendance.
Why It Matters
For investors and stakeholders tracking LEXICON PHARMACEUTICALS, INC., this filing contains several important signals. The virtual format ensures accessibility for stockholders to participate in voting and ask questions, despite the lack of in-person attendance. The company emphasizes the importance of stockholder participation, providing a specific URL and requiring a control number for access to the online meeting.
Risk Assessment
Risk Level: low — LEXICON PHARMACEUTICALS, INC. shows low risk based on this filing. The filing is a routine proxy statement (DEF 14A) and does not contain new financial or operational information, indicating a low level of immediate risk.
Analyst Insight
Stockholders should review the proxy materials to obtain their control number and understand the procedures for participating in the virtual annual meeting.
Key Numbers
- 2024 — Annual Meeting Year (2024 annual meeting of stockholders)
- May 10 — Meeting Date (Friday, May 10, 2024)
- 8:00 a.m. CDT — Meeting Time (8:00 a.m. CDT)
- 16-digit — Control Number Length (16-digit control number included with these proxy materials)
Key Players & Entities
- Lexicon Pharmaceuticals, Inc. (company) — Registrant and filer of the proxy statement
- May 10, 2024 (date) — Date of the 2024 annual meeting of stockholders
- 8:00 a.m. CDT (time) — Time of the 2024 annual meeting of stockholders
- www.virtualshareholdermeeting.com/LXRX2024 (url) — URL for attending the virtual annual meeting
- 2024 (date) — Year of the annual meeting
FAQ
When did LEXICON PHARMACEUTICALS, INC. file this DEF 14A?
LEXICON PHARMACEUTICALS, INC. filed this Proxy Statement (DEF 14A) with the SEC on March 26, 2024.
What is a DEF 14A filing?
A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by LEXICON PHARMACEUTICALS, INC. (LXRX).
Where can I read the original DEF 14A filing from LEXICON PHARMACEUTICALS, INC.?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by LEXICON PHARMACEUTICALS, INC..
What are the key takeaways from LEXICON PHARMACEUTICALS, INC.'s DEF 14A?
LEXICON PHARMACEUTICALS, INC. filed this DEF 14A on March 26, 2024. Key takeaways: The 2024 annual meeting of Lexicon Pharmaceuticals, Inc. stockholders will be held online on May 10, 2024, at 8:00 a.m. CDT.. Stockholders can attend and participate by visiting www.virtualshareholdermeeting.com/LXRX2024.. Electronic voting and question submission will be available during the virtual meeting..
Is LEXICON PHARMACEUTICALS, INC. a risky investment based on this filing?
Based on this DEF 14A, LEXICON PHARMACEUTICALS, INC. presents a relatively low-risk profile. The filing is a routine proxy statement (DEF 14A) and does not contain new financial or operational information, indicating a low level of immediate risk.
What should investors do after reading LEXICON PHARMACEUTICALS, INC.'s DEF 14A?
Stockholders should review the proxy materials to obtain their control number and understand the procedures for participating in the virtual annual meeting. The overall sentiment from this filing is neutral.
How does LEXICON PHARMACEUTICALS, INC. compare to its industry peers?
Lexicon Pharmaceuticals operates in the pharmaceutical preparations industry, focusing on the development of treatments for diseases.
Are there regulatory concerns for LEXICON PHARMACEUTICALS, INC.?
This filing is a Definitive Proxy Statement (DEF 14A) made in accordance with Section 14(a) of the Securities Exchange Act of 1934, requiring disclosure of information for soliciting stockholder votes.
Industry Context
Lexicon Pharmaceuticals operates in the pharmaceutical preparations industry, focusing on the development of treatments for diseases.
Regulatory Implications
This filing is a Definitive Proxy Statement (DEF 14A) made in accordance with Section 14(a) of the Securities Exchange Act of 1934, requiring disclosure of information for soliciting stockholder votes.
What Investors Should Do
- Obtain the 16-digit control number from proxy materials for meeting access.
- Visit www.virtualshareholdermeeting.com/LXRX2024 to attend the virtual meeting.
- Prepare to vote electronically and submit questions during the meeting.
Key Dates
- 2024-05-10: 2024 Annual Meeting of Stockholders — Stockholders will attend and vote virtually.
- 2024-03-26: Filing Date — Definitive Proxy Statement filed with the SEC.
Year-Over-Year Comparison
This filing is a Definitive Proxy Statement (DEF 14A) for the 2024 annual meeting, providing details on how to attend and participate virtually, which is a procedural update from previous filings.
Filing Stats: 4,865 words · 19 min read · ~16 pages · Grade level 11.7 · Accepted 2024-03-26 07:05:30
Key Financial Figures
- $0 — e of transaction NA (5) Total fee paid $0 o Fee paid previously with preliminar
Filing Documents
- a2024definitiveproxystatem.htm (DEF 14A) — 952KB
- image0a01a04a.jpg (GRAPHIC) — 73KB
- screenshot2024-02x29100249a.jpg (GRAPHIC) — 23KB
- 0001062822-24-000014.txt ( ) — 1086KB
From the Filing
DEF 14A 1 a2024definitiveproxystatem.htm DEF 14A Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC. 20549 SCHEDULE 14A (Rule 14A-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant Check the appropriate box o Preliminary Proxy Statement o Confidential, for Use of the Commission Only x Definitive Proxy Statement (as permitted by Rule 14a-6(e)(2)) o Definitive Additional Materials o Soliciting Material Pursuant to Rule 14a-11(c)or Rule 14a-12 LEXICON PHARMACEUTICALS, INC. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) Payment of Filing Fee (Check the appropriate box) x No fee required. o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction applies NA (2) Aggregate number of securities to which transaction applies NA (3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined) NA (4) Proposed maximum aggregate value of transaction NA (5) Total fee paid $0 o Fee paid previously with preliminary materials NA o Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. (1) Amount Previously Paid (2) Form, Schedule or Registration Statement No. (3) Filing Party (4) Date Filed March 26, 2024 TO OUR STOCKHOLDERS I am pleased to invite you to attend the 2024 annual meeting of stockholders of Lexicon Pharmaceuticals, Inc. to be held on Friday, May 10, 2024 at 800 a.m. CDT. The annual meeting will be held entirely online and you will be able to attend and participate by visiting httpwww.virtualshareholdermeeting.comLXRX2024 , where you will be able to vote electronically and submit questions. You will not be able to attend the annual meeting in person. We are taking measures so that our stockholders may still meaningfully participate in the annual meeting notwithstanding the virtual platform. You will need the 16-digit control number included with these proxy materials to attend the annual meeting. Your vote is important, regardless of the number of shares that you hold. Whether or not you plan to attend the annual meeting, I hope you will vote as soon as possible, either electronically on the Internet, by telephone or by signing and returning the enclosed proxy card. You can revoke any prior proxy by attending the annual meeting and voting electronically during the meeting or by otherwise revoking your proxy as described in the proxy statement. Thank you for your ongoing support of and continued interest in Lexicon Pharmaceuticals. Sincerely, s Lonnel Coats Lonnel Coats Chief Executive Officer LEXICON PHARMACEUTICALS, INC. 2445 Technology Forest Blvd., 11th Floor The Woodlands, Texas 77381 (281) 863-3000 NOTICE OF ANNUAL MEETING OF STOCKHOLDERS TO BE HELD MAY 10, 2024 TO OUR STOCKHOLDERS The annual meeting of stockholders of Lexicon Pharmaceuticals, Inc. will be held on Friday, May 10, 2024 at 800 a.m. CDT. The annual meeting will be held entirely online at httpwww.virtualsharesholdermeeting.comLXRX2024 . At the annual meeting, stockholders will consider and vote on the following matters the election of the three Class III directors named in this proxy statement a proposal to ratify and approve the Sixth Amended and Restated Certificate of Incorporation increasing the number of authorized shares of our common stock from 300,000,000 to 450,000,000 an advisory vote to approve the compensation paid to our named executive officers a proposal to ratify and approve the appointment of Ernst Young LLP as our independent auditors for the fiscal year ending December 31, 2024 and acting on any other business that properly comes before the annual meeting. You are entitled to vote at the annual meeting only if you are the record owner of shares of our common stock or our preferred stock designated as Series A Convertible Preferred Stock at the close of business on March 18, 2024. It is important that your shares be represented at the annual meeting whether or not you plan to attend online. Please cast your vote electronically on the Internet, by telephone or by signing and returning the enclosed proxy card as promptly as possible. If you attend the annual meeting online, and wish to do so, you may revoke the proxy and vote electronically at the annual meeting. By order of the board of directors, s Brian T. Crum Brian T. Crum Secretary The Woodlands, Texas March